MedTrace Logo

Modern Hybrid Imaging in Patients With OSCC

NCT04280159 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 265

Last updated 2020-02-21

No results posted yet for this study

Summary

Prospective diagnostic study to determine the diagnostic accuracy of preoperative 18F--fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in detecting local tumor extent, cervical lymph node metastases and distant metastases/secondary primary tumor.

Conditions

Sponsors & Collaborators

  • Wuerzburg University Hospital

    lead OTHER

Principal Investigators

  • Urs Müller-Richter, MD, DDS, PhD · Dpt. of CMF, University Hospital Wuerzburg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-28
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04280159 on ClinicalTrials.gov